- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Oncoimmune Drivers of Cancer Metastasis
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 3, Pages 554
Publisher
MDPI AG
Online
2021-02-02
DOI
10.3390/cancers13030554
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy
- (2021) Sumaiyah K. Rehman et al. CELL
- THBS1 facilitates colorectal liver metastasis through enhancing epithelial–mesenchymal transition
- (2020) X. Liu et al. Clinical & Translational Oncology
- Clinical significance of chemokine receptor antagonists
- (2020) Miao Miao et al. Expert Opinion on Drug Metabolism & Toxicology
- Novel therapeutic targets for cancer metastasis
- (2020) Konstantin Stoletov et al. Expert Review of Anticancer Therapy
- p53, cancer and the immune response
- (2020) Julianna Blagih et al. JOURNAL OF CELL SCIENCE
- PD-L1+ regulatory B cells act as a T cell suppressor in a PD-L1-dependent manner in melanoma patients with bone metastasis
- (2020) Hao Wu et al. MOLECULAR IMMUNOLOGY
- PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs
- (2020) Yujun Park et al. Cancer Research and Treatment
- Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses
- (2020) Julianna Blagih et al. Cell Reports
- Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer
- (2020) Kyungsoo Kim et al. Genome Medicine
- Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence
- (2020) Sean J. Judge et al. Frontiers in Cellular and Infection Microbiology
- The emerging role of Wnt5a in the promotion of a pro-inflammatory and immunosuppressive tumor microenvironment
- (2020) Pablo Lopez-Bergami et al. CANCER AND METASTASIS REVIEWS
- Role of cancer stem cells in the development of giant cell tumor of bone
- (2020) Abdul Rouf War et al. Cancer Cell International
- IL33 Is a Key Driver of Treatment Resistance of Cancer
- (2020) Chie Kudo-Saito et al. CANCER RESEARCH
- Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion
- (2020) Yugang Wang et al. Translational Oncology
- The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker
- (2020) Behrad Darvishi et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Interleukin 35 Regulatory B Cells
- (2020) Jin Kyeong Choi et al. JOURNAL OF MOLECULAR BIOLOGY
- ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung
- (2020) Martijn J. Schuijs et al. NATURE IMMUNOLOGY
- RAS-targeted therapies: is the undruggable drugged?
- (2020) Amanda R. Moore et al. NATURE REVIEWS DRUG DISCOVERY
- EMT, MET, Plasticity, and Tumor Metastasis
- (2020) Basil Bakir et al. TRENDS IN CELL BIOLOGY
- Advances in chimeric antigen receptor T cells
- (2020) Ofrat Beyar-Katz et al. CURRENT OPINION IN HEMATOLOGY
- The role of microenvironment in tumor angiogenesis
- (2020) Xianjie Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- IDO Expression in Cancer: Different Compartment, Different Functionality?
- (2020) Annabel Meireson et al. Frontiers in Immunology
- NK cells-directed therapies target circulating tumor cells and metastasis
- (2020) Hassan Dianat-Moghadam et al. CANCER LETTERS
- Therapeutic implications of cancer epithelial-mesenchymal transition (EMT)
- (2019) Eunae Sandra Cho et al. ARCHIVES OF PHARMACAL RESEARCH
- Indoleamine Dioxygenase Inhibitors: Clinical Rationale and Current Development
- (2019) Mayanne M. T. Zhu et al. Current Oncology Reports
- Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
- (2019) Anna Wawruszak et al. Cancers
- Targeting PI3K in cancer: mechanisms and advances in clinical trials
- (2019) Jing Yang et al. Molecular Cancer
- Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2
- (2019) Serena Lucotti et al. JOURNAL OF CLINICAL INVESTIGATION
- The Contribution of the Immune System in Bone Metastasis Pathogenesis
- (2019) Lisha Xiang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF-κB/Notch1 pathway in non-small cell lung cancer
- (2019) Li Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer-associated fibroblasts: how do they contribute to metastasis?
- (2019) Mei Qi Kwa et al. CLINICAL & EXPERIMENTAL METASTASIS
- Hyperprogression under Immunotherapy
- (2019) Frelaut et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-33/ST2 signaling promotes hepatocellular carcinoma cell stemness expansion through activating JNK pathway
- (2019) Rongrong Zhao et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
- (2019) Yang Hao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma
- (2019) Xiaochen Wang et al. JOURNAL OF HEPATOLOGY
- TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
- (2019) Omar Khan et al. NATURE
- IL-1β, IL-23, and TGF-β drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation
- (2019) Korneliusz Golebski et al. Nature Communications
- A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer
- (2019) Zishuo Ian Hu et al. Cancer Medicine
- A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
- (2019) R.K. Kelley et al. Clinical and Translational Gastroenterology
- Future Needs in Mast Cell Biology
- (2019) Varricchi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- Neoantigen vaccine: an emerging tumor immunotherapy
- (2019) Miao Peng et al. Molecular Cancer
- Immuno-oncology drug development goes global
- (2019) Jia Xin Yu et al. NATURE REVIEWS DRUG DISCOVERY
- Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance
- (2019) Sarah R. Amend et al. PROSTATE
- Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
- (2019) Marijo Bilusic et al. Journal for ImmunoTherapy of Cancer
- Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity
- (2019) Xiao-Guang Yang et al. Frontiers in Oncology
- A review of canakinumab and its therapeutic potential for non-small cell lung cancer
- (2019) Kara M. Schenk et al. ANTI-CANCER DRUGS
- CAR-NK for tumor immunotherapy: Clinical transformation and future prospects
- (2019) Wenxiu Wang et al. CANCER LETTERS
- Tumor angiogenesis: causes, consequences, challenges and opportunities
- (2019) Roberta Lugano et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Hyaluronan-CD44 axis orchestrates cancer stem cell functions
- (2019) Spyros S. Skandalis et al. CELLULAR SIGNALLING
- Facts and New Hopes on Selective FGFR Inhibitors in Solid Tumors
- (2019) Francesco Facchinetti et al. CLINICAL CANCER RESEARCH
- T Regulatory Cells and Priming the Suppressive Tumor Microenvironment
- (2019) Christina M. Paluskievicz et al. Frontiers in Immunology
- Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response
- (2019) Laura Lorenzo-Sanz et al. Cancer Microenvironment
- Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion
- (2019) Yuanyuan Jiang et al. CANCER LETTERS
- Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection
- (2019) William H. Hudson et al. IMMUNITY
- ILC2s: New Actors in Tumor Immunity
- (2019) Giuseppe Ercolano et al. Frontiers in Immunology
- Personalized neoantigen vaccines: A new approach to cancer immunotherapy
- (2018) Amanda R. Aldous et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells
- (2018) Brian J. Morrison et al. BMC CANCER
- A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
- (2018) Natalie Cook et al. BRITISH JOURNAL OF CANCER
- Targeting myeloid-derived suppressor cells for cancer immunotherapy
- (2018) Yijun Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pericytes in the Premetastatic Niche
- (2018) Ana E. Paiva et al. CANCER RESEARCH
- When worlds collide: Th17 and Treg cells in cancer and autoimmunity
- (2018) Hannah M. Knochelmann et al. Cellular & Molecular Immunology
- Follistatin-like 1 in development and human diseases
- (2018) Andrea Mattiotti et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy
- (2018) Shirin Eyvazi et al. CURRENT CANCER DRUG TARGETS
- NKG2D and its ligands in cancer
- (2018) Payal Dhar et al. CURRENT OPINION IN IMMUNOLOGY
- E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells
- (2018) Jiaoe Chen et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- CD133: beyond a cancer stem cell biomarker
- (2018) Amir Barzegar Behrooz et al. JOURNAL OF DRUG TARGETING
- Advances in studies of tyrosine kinase inhibitors and their acquired resistance
- (2018) Qinlian Jiao et al. Molecular Cancer
- FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signalling pathway
- (2018) Chuansha Gu et al. Cell Death & Disease
- Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
- (2018) Mana Taki et al. Nature Communications
- STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
- (2018) Jung-Mao Hsu et al. Nature Communications
- Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses
- (2018) Stefan Schülke Frontiers in Immunology
- First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer
- (2018) C Massard et al. ANNALS OF ONCOLOGY
- Emerging strategies for combination checkpoint modulators in cancer immunotherapy
- (2018) Aleksandra Popovic et al. JOURNAL OF CLINICAL INVESTIGATION
- CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest
- (2018) Shom Goel et al. TRENDS IN CELL BIOLOGY
- Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization
- (2018) Chih-Chan Lee et al. Nature Communications
- Dysregulation in Actin Cytoskeletal Organization Drives Increased Stiffness and Migratory Persistence in Polyploidal Giant Cancer Cells
- (2018) Botai Xuan et al. Scientific Reports
- Blocking the FSTL1-DIP2A Axis Improves Anti-tumor Immunity
- (2018) Chie Kudo-Saito et al. Cell Reports
- Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
- (2018) Roberto Ferrara et al. JAMA Oncology
- Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
- (2018) Peixin Dong et al. Frontiers in Oncology
- Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance
- (2018) Monish Ram Makena et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors
- (2018) David C. Smith et al. INVESTIGATIONAL NEW DRUGS
- TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell Mediated Regression of Pancreatic Cancer
- (2018) Daniel R Principe et al. MOLECULAR CANCER THERAPEUTICS
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
- (2018) Susanne H. Baumeister et al. Cancer Immunology Research
- Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis
- (2017) Minal Garg EXPERT REVIEWS IN MOLECULAR MEDICINE
- PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
- (2017) Sheema Almozyan et al. INTERNATIONAL JOURNAL OF CANCER
- Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
- (2017) Masaru Katoh INTERNATIONAL JOURNAL OF ONCOLOGY
- Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status
- (2017) Tsuyoshi Hamada et al. JOURNAL OF CLINICAL ONCOLOGY
- EGF hijacks miR-198/FSTL1 wound-healing switch and steers a two-pronged pathway toward metastasis
- (2017) Gopinath M. Sundaram et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mesenchymal stem cells: key players in cancer progression
- (2017) Sarah M. Ridge et al. Molecular Cancer
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in�vitro through activation of the Hedgehog pathway
- (2017) Huijie Zhuang et al. ONCOLOGY REPORTS
- Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression
- (2017) Chongbiao Huang et al. Nature Communications
- Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation
- (2017) Yadi Wu et al. Nature Communications
- CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1
- (2017) Tongzheng Liu et al. Nature Communications
- Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824)
- (2017) Caroline Jochems et al. Oncotarget
- PD1 signal transduction pathways in T cells
- (2017) Hugo Arasanz et al. Oncotarget
- Myeloid-Derived Suppressor Cells
- (2017) Dmitry I. Gabrilovich Cancer Immunology Research
- Are Mast Cells MASTers in Cancer?
- (2017) Gilda Varricchi et al. Frontiers in Immunology
- The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200
- (2017) Muhammad Zaeem Noman et al. OncoImmunology
- More than a scaffold: Stromal modulation of tumor immunity
- (2016) Anna Johansson et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial
- (2016) R. Xu et al. CLINICAL CANCER RESEARCH
- A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer
- (2016) Shubham Pant et al. EUROPEAN JOURNAL OF CANCER
- Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy
- (2016) Jesus I. Luna et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Interleukin-35 Limits Anti-Tumor Immunity
- (2016) Meghan E. Turnis et al. IMMUNITY
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- CD4 + CD25 + regulatory T cells in tumor immunity
- (2016) Xin Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Epithelial-mesenchymal plasticity in circulating tumor cells
- (2016) Catherine Alix-Panabières et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Combination of Eribulin and Aurora A Inhibitor MLN8237 Prevents Metastatic Colonization and Induces Cytotoxic Autophagy in Breast Cancer
- (2016) V. K. Kozyreva et al. MOLECULAR CANCER THERAPEUTICS
- Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
- (2016) Yufang Shi et al. NATURE REVIEWS DRUG DISCOVERY
- A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
- (2016) Alba A. Brandes et al. NEURO-ONCOLOGY
- Somatic polyploidy is associated with the upregulation of c-MYC interacting genes and EMT-like signature
- (2016) Alejandro Vazquez-Martin et al. Oncotarget
- Targeting the CCL2-CCR2 signaling axis in cancer metastasis
- (2016) Su Yin Lim et al. Oncotarget
- B cell regulation of the anti-tumor response and role in carcinogenesis
- (2016) Marc Schwartz et al. Journal for ImmunoTherapy of Cancer
- Interleukin-6 as a Therapeutic Target
- (2015) J.-F. Rossi et al. CLINICAL CANCER RESEARCH
- Immunity, inflammation, and cancer: an eternal fight between good and evil
- (2015) Shabnam Shalapour et al. JOURNAL OF CLINICAL INVESTIGATION
- The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer
- (2015) Fei Fei et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Immunosuppressive cells in tumor immune escape and metastasis
- (2015) Yang Liu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- (2015) Kari R. Fischer et al. NATURE
- Overcoming T cell exhaustion in infection and cancer
- (2015) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors
- (2015) Ashvinikumar V. Gavai et al. ACS Medicinal Chemistry Letters
- Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway
- (2015) Ge Qin et al. Oncotarget
- EMT, CTCs and CSCs in tumor relapse and drug-resistance
- (2015) Abhisek Mitra et al. Oncotarget
- HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
- (2015) D. M. Woods et al. Cancer Immunology Research
- Chemokine Receptor-Specific Antibodies in Cancer Immunotherapy: Achievements and Challenges
- (2015) Maria Vela et al. Frontiers in Immunology
- Aurora Kinase Inhibitors: Current Status and Outlook
- (2015) Vassilios Bavetsias et al. Frontiers in Oncology
- Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma
- (2015) Aparna Jayachandran et al. Oncotarget
- Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
- (2015) Ulrike M. Litzenburger et al. Oncotarget
- Cluster of differentiation 166 (CD166) regulates cluster of differentiation (CD44) via NF-κB in liver cancer cell line Bel-7402
- (2014) Lifang Ma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis
- (2014) Taranjit S. Gujral et al. CELL
- The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells
- (2014) Torben Redmer et al. PLoS One
- Signaling mechanisms of the epithelial-mesenchymal transition
- (2014) D. M. Gonzalez et al. Science Signaling
- Contribution of p53 to Metastasis
- (2014) E. Powell et al. Cancer Discovery
- Immunoevasive Pericytes From Human Pluripotent Stem Cells Preferentially Modulate Induction of Allogeneic Regulatory T Cells
- (2014) Hagit Domev et al. Stem Cells Translational Medicine
- Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer
- (2014) Jermaine Coward et al. Frontiers in Oncology
- p53 Attenuates the oncogenic Ras-induced epithelial–mesenchymal transition in human mammary epithelial cells
- (2013) Jianchao Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The emerging roles of AhR in physiology and immunity
- (2013) Nan Hao et al. BIOCHEMICAL PHARMACOLOGY
- Targeting FSTL1 Prevents Tumor Bone Metastasis and Consequent Immune Dysfunction
- (2013) C. Kudo-Saito et al. CANCER RESEARCH
- Aspirin and Colorectal Cancer: Back to the Future
- (2013) David Tougeron et al. CLINICAL CANCER RESEARCH
- Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell-Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4
- (2013) A. Volonte et al. JOURNAL OF IMMUNOLOGY
- Follistatin-Like 1: A Potential Mediator of Inflammation in Obesity
- (2013) Nengguang Fan et al. MEDIATORS OF INFLAMMATION
- Generation of cancer stem-like cells through the formation of polyploid giant cancer cells
- (2013) S Zhang et al. ONCOGENE
- p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1
- (2013) Bei Wang et al. Nature Communications
- COX-2 in cancer: Gordian knot or Achilles heel?
- (2013) Ioannis Stasinopoulos et al. Frontiers in Pharmacology
- Giant cell tumor of bone: A basic science perspective
- (2012) Robert W. Cowan et al. BONE
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
- (2012) Helge Siemens et al. CELL CYCLE
- CCL2 is critical for immunosuppression to promote cancer metastasis
- (2012) Chie Kudo-Saito et al. CLINICAL & EXPERIMENTAL METASTASIS
- Mechanisms of mesenchymal stromal cell immunomodulation
- (2012) Karen English IMMUNOLOGY AND CELL BIOLOGY
- Aurora-A promotes gefitinib resistance via a NF-κB signaling pathway in p53 knockdown lung cancer cells
- (2011) Chun Chi Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Strength of TCR-Peptide/MHC Interactions and In Vivo T Cell Responses
- (2011) E. Corse et al. JOURNAL OF IMMUNOLOGY
- Functional Interactions between Retinoblastoma and c-MYC in a Mouse Model of Hepatocellular Carcinoma
- (2011) Louis A. Saddic et al. PLoS One
- Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis
- (2011) Dawei Li et al. ARTHRITIS RESEARCH & THERAPY
- Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis
- (2010) David C. Wilson et al. ARTHRITIS AND RHEUMATISM
- Aurora B Interacts with NIR-p53, Leading to p53 Phosphorylation in Its DNA-binding Domain and Subsequent Functional Suppression
- (2010) Liming Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells
- (2009) Chie Kudo-Saito et al. CANCER CELL
- p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
- (2009) Shu-Ping Wang et al. NATURE CELL BIOLOGY
- The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
- (2009) N. Stanietsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulatory T Cells: Mechanisms of Differentiation and Function
- (2007) Steven Z. Josefowicz et al. Annual Review of Immunology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started